These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. GM1 antibody in Guillain-Barre syndrome after Campylobacter jejuni infection. Tang J, Yuan J, Hao H. Chin Med J (Engl); 1995 Apr; 108(4):262-4. PubMed ID: 7789212 [Abstract] [Full Text] [Related]
11. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome. Yuki N, Susuki K, Koga M, Nishimoto Y, Odaka M, Hirata K, Taguchi K, Miyatake T, Furukawa K, Kobata T, Yamada M. Proc Natl Acad Sci U S A; 2004 Aug 03; 101(31):11404-9. PubMed ID: 15277677 [Abstract] [Full Text] [Related]
12. [Campylobacter jejuni enteritis and Guillain-Barré syndrome]. Yuki N. Rinsho Byori; 1999 Aug 03; 47(8):713-8. PubMed ID: 10511801 [Abstract] [Full Text] [Related]
18. Carbohydrate mimicry of Campylobacter jejuni lipooligosaccharide is critical for the induction of anti-GM1 antibody and neuropathy. Shu XM, Cai FC, Zhang XP. Muscle Nerve; 2006 Feb 03; 33(2):225-31. PubMed ID: 16270308 [Abstract] [Full Text] [Related]
19. Lipopolysaccharides in the development of the Guillain-Barré syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies. Prendergast MM, Moran AP. J Endotoxin Res; 2000 Feb 03; 6(5):341-59. PubMed ID: 11521055 [Abstract] [Full Text] [Related]